aluates Reports

$ 0.0

Automative

Respiratory Syncytial Virus (RSV) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-25S7795

Global Respiratory Syncytial Virus RSV Testing Market Insights and Forecast to 2028

BUY CHAPTERS

Respiratory Syncytial Virus (RSV) Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-25S7795

Report

December 2024

Pages:118

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

Biomerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

Respiratory Syncytial Virus (RSV) Testing - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Respiratory Syncytial Virus (RSV) Testing - Market

The global market for Respiratory Syncytial Virus (RSV) Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus (RSV) Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Respiratory Syncytial Virus (RSV) Testing by region & country, by Type, and by Application.

The Respiratory Syncytial Virus (RSV) Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus (RSV) Testing.

Market Segmentation

Scope of Respiratory Syncytial Virus (RSV) Testing - Market Report

Report Metric	Details
Report Name	Respiratory Syncytial Virus (RSV) Testing - Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type:	Testing Services Testing Kits Others
Segment by Application	Hospitals POCT Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Respiratory Syncytial Virus (RSV) Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Respiratory Syncytial Virus (RSV) Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Respiratory Syncytial Virus (RSV) Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus (RSV) Testing - Market report?

Ans: The main players in the Respiratory Syncytial Virus (RSV) Testing - Market are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics)

What are the Application segmentation covered in the Respiratory Syncytial Virus (RSV) Testing - Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus (RSV) Testing - Market report are Hospitals, POCT, Others

What are the Type segmentation covered in the Respiratory Syncytial Virus (RSV) Testing - Market report?

Ans: The Types covered in the Respiratory Syncytial Virus (RSV) Testing - Market report are Testing Services, Testing Kits, Others

Recommended Reports

Respiratory Diagnostics

Testing Kits and Services

Ventilation and Monitoring

1 Market Overview

1.1 Respiratory Syncytial Virus (RSV) Testing Product Introduction

1.2 Global Respiratory Syncytial Virus (RSV) Testing Market Size Forecast

1.3 Respiratory Syncytial Virus (RSV) Testing Market Trends & Drivers

1.3.1 Respiratory Syncytial Virus (RSV) Testing Industry Trends

1.3.2 Respiratory Syncytial Virus (RSV) Testing Market Drivers & Opportunity

1.3.3 Respiratory Syncytial Virus (RSV) Testing Market Challenges

1.3.4 Respiratory Syncytial Virus (RSV) Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Respiratory Syncytial Virus (RSV) Testing Players Revenue Ranking (2023)

2.2 Global Respiratory Syncytial Virus (RSV) Testing Revenue by Company (2019-2024)

2.3 Key Companies Respiratory Syncytial Virus (RSV) Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Respiratory Syncytial Virus (RSV) Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus (RSV) Testing

2.6 Respiratory Syncytial Virus (RSV) Testing Market Competitive Analysis

2.6.1 Respiratory Syncytial Virus (RSV) Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Respiratory Syncytial Virus (RSV) Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus (RSV) Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Testing Services

3.1.2 Testing Kits

3.1.3 Others

3.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type

3.2.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Type (2019-2030)

3.2.3 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 POCT

4.1.3 Others

4.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application

4.2.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Application (2019-2030)

4.2.3 Global Respiratory Syncytial Virus (RSV) Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region

5.1.1 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2019-2024)

5.1.3 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2025-2030)

5.1.4 Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

5.2.2 North America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

5.3.2 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

5.4.2 Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

5.5.2 South America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value

6.3 United States

6.3.1 United States Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.3.2 United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.4.2 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.5.2 China Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.6.2 Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.7.2 South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.8.2 Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019-2030

6.9.2 India Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Respiratory Syncytial Virus (RSV) Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 BD

7.1.1 BD Profile

7.1.2 BD Main Business

7.1.3 BD Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.1.4 BD Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.1.5 BD Recent Developments

7.2 Abbot (Alere)

7.2.1 Abbot (Alere) Profile

7.2.2 Abbot (Alere) Main Business

7.2.3 Abbot (Alere) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.2.4 Abbot (Alere) Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Abbot (Alere) Recent Developments

7.3 Quidel

7.3.1 Quidel Profile

7.3.2 Quidel Main Business

7.3.3 Quidel Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.3.4 Quidel Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.3.5 Roche Recent Developments

7.4 Roche

7.4.1 Roche Profile

7.4.2 Roche Main Business

7.4.3 Roche Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.4.4 Roche Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.4.5 Roche Recent Developments

7.5 Thermo Fisher Scientific

7.5.1 Thermo Fisher Scientific Profile

7.5.2 Thermo Fisher Scientific Main Business

7.5.3 Thermo Fisher Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.5.4 Thermo Fisher Scientific Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.5.5 Thermo Fisher Scientific Recent Developments

7.6 Meridian Bioscience

7.6.1 Meridian Bioscience Profile

7.6.2 Meridian Bioscience Main Business

7.6.3 Meridian Bioscience Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.6.4 Meridian Bioscience Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.6.5 Meridian Bioscience Recent Developments

7.7 Analytik Jena

7.7.1 Analytik Jena Profile

7.7.2 Analytik Jena Main Business

7.7.3 Analytik Jena Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.7.4 Analytik Jena Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.7.5 Analytik Jena Recent Developments

7.8 Princeton BioMeditech Corporation

7.8.1 Princeton BioMeditech Corporation Profile

7.8.2 Princeton BioMeditech Corporation Main Business

7.8.3 Princeton BioMeditech Corporation Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.8.4 Princeton BioMeditech Corporation Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.8.5 Princeton BioMeditech Corporation Recent Developments

7.9 BioMerieux

7.9.1 BioMerieux Profile

7.9.2 BioMerieux Main Business

7.9.3 BioMerieux Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.9.4 BioMerieux Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.9.5 BioMerieux Recent Developments

7.10 Sekisui Diagnostics

7.10.1 Sekisui Diagnostics Profile

7.10.2 Sekisui Diagnostics Main Business

7.10.3 Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.10.4 Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.10.5 Sekisui Diagnostics Recent Developments

7.11 Response Biomedical

7.11.1 Response Biomedical Profile

7.11.2 Response Biomedical Main Business

7.11.3 Response Biomedical Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.11.4 Response Biomedical Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.11.5 Response Biomedical Recent Developments

7.12 SA Scientific

7.12.1 SA Scientific Profile

7.12.2 SA Scientific Main Business

7.12.3 SA Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.12.4 SA Scientific Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.12.5 SA Scientific Recent Developments

7.13 DiaSorin (Focus Diagnostics)

7.13.1 DiaSorin (Focus Diagnostics) Profile

7.13.2 DiaSorin (Focus Diagnostics) Main Business

7.13.3 DiaSorin (Focus Diagnostics) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

7.13.4 DiaSorin (Focus Diagnostics) Respiratory Syncytial Virus (RSV) Testing Revenue (US$ Million) & (2019-2024)

7.13.5 DiaSorin (Focus Diagnostics) Recent Developments

8 Industry Chain Analysis

8.1 Respiratory Syncytial Virus (RSV) Testing Industrial Chain

8.2 Respiratory Syncytial Virus (RSV) Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Respiratory Syncytial Virus (RSV) Testing Sales Model

8.5.2 Sales Channel

8.5.3 Respiratory Syncytial Virus (RSV) Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

Biomerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

List of Tables

Table 1. Respiratory Syncytial Virus (RSV) Testing Market Trends

Table 2. Respiratory Syncytial Virus (RSV) Testing Market Drivers & Opportunity

Table 3. Respiratory Syncytial Virus (RSV) Testing Market Challenges

Table 4. Respiratory Syncytial Virus (RSV) Testing Market Restraints

Table 5. Global Respiratory Syncytial Virus (RSV) Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Respiratory Syncytial Virus (RSV) Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Respiratory Syncytial Virus (RSV) Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Respiratory Syncytial Virus (RSV) Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Respiratory Syncytial Virus (RSV) Testing

Table 10. Global Respiratory Syncytial Virus (RSV) Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus (RSV) Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Respiratory Syncytial Virus (RSV) Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. BD Basic Information List

Table 32. BD Description and Business Overview

Table 33. BD Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of BD (2019-2024)

Table 35. BD Recent Developments

Table 36. Abbot (Alere) Basic Information List

Table 37. Abbot (Alere) Description and Business Overview

Table 38. Abbot (Alere) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Abbot (Alere) (2019-2024)

Table 40. Abbot (Alere) Recent Developments

Table 41. Quidel Basic Information List

Table 42. Quidel Description and Business Overview

Table 43. Quidel Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Quidel (2019-2024)

Table 45. Quidel Recent Developments

Table 46. Roche Basic Information List

Table 47. Roche Description and Business Overview

Table 48. Roche Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Roche (2019-2024)

Table 50. Roche Recent Developments

Table 51. Thermo Fisher Scientific Basic Information List

Table 52. Thermo Fisher Scientific Description and Business Overview

Table 53. Thermo Fisher Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Thermo Fisher Scientific (2019-2024)

Table 55. Thermo Fisher Scientific Recent Developments

Table 56. Meridian Bioscience Basic Information List

Table 57. Meridian Bioscience Description and Business Overview

Table 58. Meridian Bioscience Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Meridian Bioscience (2019-2024)

Table 60. Meridian Bioscience Recent Developments

Table 61. Analytik Jena Basic Information List

Table 62. Analytik Jena Description and Business Overview

Table 63. Analytik Jena Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Analytik Jena (2019-2024)

Table 65. Analytik Jena Recent Developments

Table 66. Princeton BioMeditech Corporation Basic Information List

Table 67. Princeton BioMeditech Corporation Description and Business Overview

Table 68. Princeton BioMeditech Corporation Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Princeton BioMeditech Corporation (2019-2024)

Table 70. Princeton BioMeditech Corporation Recent Developments

Table 71. BioMerieux Basic Information List

Table 72. BioMerieux Description and Business Overview

Table 73. BioMerieux Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of BioMerieux (2019-2024)

Table 75. BioMerieux Recent Developments

Table 76. Sekisui Diagnostics Basic Information List

Table 77. Sekisui Diagnostics Description and Business Overview

Table 78. Sekisui Diagnostics Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Sekisui Diagnostics (2019-2024)

Table 80. Sekisui Diagnostics Recent Developments

Table 81. Response Biomedical Basic Information List

Table 82. Response Biomedical Description and Business Overview

Table 83. Response Biomedical Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 84. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of Response Biomedical (2019-2024)

Table 85. Response Biomedical Recent Developments

Table 86. SA Scientific Basic Information List

Table 87. SA Scientific Description and Business Overview

Table 88. SA Scientific Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 89. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of SA Scientific (2019-2024)

Table 90. SA Scientific Recent Developments

Table 91. DiaSorin (Focus Diagnostics) Basic Information List

Table 92. DiaSorin (Focus Diagnostics) Description and Business Overview

Table 93. DiaSorin (Focus Diagnostics) Respiratory Syncytial Virus (RSV) Testing Products, Services and Solutions

Table 94. Revenue (US$ Million) in Respiratory Syncytial Virus (RSV) Testing Business of DiaSorin (Focus Diagnostics) (2019-2024)

Table 95. DiaSorin (Focus Diagnostics) Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Respiratory Syncytial Virus (RSV) Testing Downstream Customers

Table 99. Respiratory Syncytial Virus (RSV) Testing Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Respiratory Syncytial Virus (RSV) Testing Product Picture

Figure 2. Global Respiratory Syncytial Virus (RSV) Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Respiratory Syncytial Virus (RSV) Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. Respiratory Syncytial Virus (RSV) Testing Report Years Considered

Figure 5. Global Respiratory Syncytial Virus (RSV) Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Syncytial Virus (RSV) Testing Revenue in 2023

Figure 7. Respiratory Syncytial Virus (RSV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Testing Services Picture

Figure 9. Testing Kits Picture

Figure 10. Others Picture

Figure 11. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Respiratory Syncytial Virus (RSV) Testing Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospitals

Figure 14. Product Picture of POCT

Figure 15. Product Picture of Others

Figure 16. Global Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Respiratory Syncytial Virus (RSV) Testing Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Respiratory Syncytial Virus (RSV) Testing Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Respiratory Syncytial Virus (RSV) Testing Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Respiratory Syncytial Virus (RSV) Testing Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Respiratory Syncytial Virus (RSV) Testing Sales Value (%), (2019-2030)

Figure 29. United States Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 35. China Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 37. China Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 47. India Respiratory Syncytial Virus (RSV) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Respiratory Syncytial Virus (RSV) Testing Sales Value by Type (%), 2023 VS 2030

Figure 49. India Respiratory Syncytial Virus (RSV) Testing Sales Value by Application (%), 2023 VS 2030

Figure 50. Respiratory Syncytial Virus (RSV) Testing Industrial Chain

Figure 51. Respiratory Syncytial Virus (RSV) Testing Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Respiratory Syncytial Virus RSV Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Pathogen Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Syncytial Virus Treatment Market Research Report 2024

Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Panel Testing Market Research Report 2024

Respiratory Analysers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Portable Respiratory Monitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Care Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Respirators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Supplied air Respirators SARs Market Research Report 2025

Respiratory Therapy Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pediatric Respiratory Syncytial Virus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Syncytial Virus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Syncytial Virus RSV Infections Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Respiratory Syncytial Virus Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respirator Leak proofing Tester and Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Pathogen Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immunohematology Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Portable Respiratory Monitoring Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions